SCHEMBL1177112

SCHEMBL1177112

CC(=O)Nc1c(S(=O)(=O)Oc2ccccc2)ccc2ccccc12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.49
ABCC9 O60706 1/20 0.47
ABCC8 Q09428 1/20 0.47
KCNJ11 Q14654 1/20 0.47
KCNJ8 Q15842 1/20 0.47
LMNA P02545 2/20 0.44
G6PD P11413 1/20 0.41
KDM4E B2RXH2 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2C9 P11712 1/20 0.40
IDO1 P14902 1/20 0.40
MAPT P10636 4/20 0.40
ALDH1A1 P00352 3/20 0.40
ENPP1 P22413 2/20 0.40
ENPP3 O14638 1/20 0.40
ENPP2 Q13822 1/20 0.40
HCRTR1 O43613 1/20 0.40
MEN1 O00255 5/20 0.40
KMT2A Q03164 5/20 0.40
RECQL P46063 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1177111 0.87 ENPP1 (0.40) POLBG6PDENPP1ENPP3ENPP2
SCHEMBL10563277 0.80 ABCC9 (0.54) POLBABCC9ABCC8KCNJ11KCNJ8
SCHEMBL1176670 0.78 PGR (0.37) LMNAG6PDKDM4EMAPTALDH1A1
SCHEMBL1176668 0.78 PGR (0.37) LMNAG6PDENPP1ENPP3ENPP2
SCHEMBL6912768 0.74 PGR (0.42) LMNAALDH1A1ENPP1ENPP3ENPP2
SCHEMBL5176359 0.72 CA1 (0.53) LMNAMEN1KMT2A
SCHEMBL7746823 0.71 ABCC9 (0.56) POLBABCC9ABCC8KCNJ11KCNJ8
SCHEMBL9646471 0.71 POLB (0.59) POLBABCC9ABCC8KCNJ11KCNJ8
SCHEMBL20194455 0.70 KCNJ11 (0.59) POLBABCC9ABCC8KCNJ11KCNJ8
SCHEMBL1806258 0.70 ABCC9 (0.59) POLBABCC9ABCC8KCNJ11KCNJ8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110045397-A1 CHARGE CONTROL AGENT AND RELATED ART KURODA KAZUYOSHI 2011-02-24 US disclosed
US-20090053641-A1 CHARGE CONTROL AGENT AND RELATED ART ORIENT CHEMICAL INDUSTRIES, LTD. (JP) 2009-02-26 US disclosed
EP-1862860-A1 CHARGE CONTROL AGENT AND RELATED TECHNIQUE Orient Chemical Industries, Ltd. (JP) 2007-12-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090053641-A1 CHARGE CONTROL AGENT AND RELATED ART H1-4, CECR2, DOT1L POLB 2246/4885ABCC9 3244/4885ABCC8 3673/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.